Delivery Order SPE2DB20D3103-SPE2DB25FP6L6
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,398.46 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $3,007.07 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,677.69 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,367.29 to AmerisourceBergen Drug Corp for the supply of 100 capsules of Vyvanse 70 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,675.40 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder and binge eating disorder. The contract, which commenced on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $1,467.15 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The contract, awarded on July 30, 2025, with completion by July 31, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.13 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.38 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order represents a single-transaction procurement under a competitive, non-set-aside arrangement. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $23,532.47 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a controlled-release medication commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, issued on July 30, 2025, represents performance through July 31, 2025, and was not designated as a set-aside procurement. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...